Skip to content
Oncology Research Hub

Research area

Prostate Cancer clinical trials

Studies in prostate cancer test investigational medications, imaging methods, and ways of monitoring across the stages of the disease. If you are looking for yourself or for someone you care for, Oncology Research Hub can help you learn whether a study might be a fit.

Updated

Call (888) 343-1186
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Prostate cancer studies in numbers

prostate cancer studies recruiting in the U.S.
594
states with a study site
51
studies that accept healthy volunteers
41

Source: ClinicalTrials.gov. Data processed .

Find prostate cancer studies by state

These states have the most studies recruiting right now.

Prostate cancer studies recruiting now

As of November 16, 2026, 594 prostate cancer studies are recruiting participants in the United States, according to ClinicalTrials.gov. This is what they have in common.

What they test

  • medications316
  • other approaches129
  • procedures107
  • radiation80
  • devices51

A study can test more than one.

Main purpose

  • treating a condition345
  • diagnosis47
  • supportive care40
  • how care is delivered22

Phase

  • Early Phase 114
  • Phase 181
  • Phase 1/266
  • Phase 2143
  • Phase 2/36
  • Phase 341
  • Phase 411
  • No phase133
  • Observational99

Studies of devices and behavioral approaches have no phase.

Who runs them

  • university, hospital or other394
  • industry166
  • government34

Who they enroll

  • adults (18 to 64)588
  • older adults (65 and over)592
  • children (under 18)23

41 also accept healthy volunteers.

These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.

Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 594 studies.

Recently updated prostate cancer studies

The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.

  1. Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

    • Phase 2
    • Ages 18 and older
    • Male participants
    Sponsor
    VA Office of Research and Development
    Recruiting in
    Ann Arbor, MI · Aurora, CO · Boise, ID · and 12 more U.S. locations
    Registry record
    NCT04038502 · updated
  2. High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

    • Phase 2
    • Ages 18 and older
    • Male participants
    Sponsor
    VA Office of Research and Development
    Recruiting in
    Aurora, CO · Charleston, SC · Decatur, GA · and 13 more U.S. locations
    Registry record
    NCT05011383 · updated
  3. Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial)

    • No phase
    • All ages
    • Male participants
    Sponsor
    University of California, San Diego
    Recruiting in
    La Jolla, CA
    Registry record
    NCT05882253 · updated
  4. Folate Study in Men With Advanced Prostate Cancer

    • Phase 2
    • Ages 18 and older
    • Male participants
    Sponsor
    University of California, San Diego
    Recruiting in
    La Jolla, CA
    Registry record
    NCT06536374 · updated
  5. Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance

    • Phase 2
    • Ages 18 to 120
    • Male participants
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Bethesda, MD
    Registry record
    NCT07574541 · updated
  6. Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer

    • Phase 1/2
    • Ages 18 to 120
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Bethesda, MD
    Registry record
    NCT07667400 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in the United States on ClinicalTrials.gov.

What prostate cancer studies look at

Researchers in prostate cancer are studying investigational medications, imaging methods, and monitoring approaches at different stages of the disease. No two studies are alike. Each one is built around a single, specific question, and that question shapes what you, or the person you are caring for, would be asked to do.

Everything tested in a study is investigational. Researchers are still learning how well it works and what risks it carries. That is why the study exists.

Who may be able to take part

Requirements are set study by study. Age, health history, current medications, and the way a condition affects you can all be part of them, and some studies also enroll people who do not have the condition.

Working out eligibility is not something you or your family have to do alone. The study team checks it at a screening visit. Read how eligibility and screening work.

What taking part usually involves

  1. A first conversation

    The first conversation is with a coordinator, who describes the study in general terms and answers your questions before anything else happens.

  2. Informed consent

    A complete written description of the study comes to you from the study team, and the known risks are part of that document. Agreeing or not is then your decision.

  3. Screening

    Screening uses health questions and tests to show whether the study is suitable for you. Some people who are screened do not go on to take part.

  4. Study visits

    Joining means coming to scheduled visits so the team can follow your health. You are free to leave the study at any time.

Questions about prostate cancer studies

Do I need a diagnosis to join a study about prostate cancer?

This varies by study. A confirmed diagnosis is required for some, while in others the team assesses you during screening. The study team will let you know which applies to you.

Would I have to change the care I receive now?

No care should be changed on your own. Whether current care can continue differs from one study to the next. The study doctor goes over this with you, and before you decide you can discuss it with your own doctor.

Is there a cost to take part?

As a rule, participants are not charged for the study medication, for tests done as part of the study, or for visits the study requires. See how costs work in more detail.

Ask about prostate cancer studies

A coordinator will contact you after you share a few details. Asking commits you to nothing.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Independent information

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 343-1186

or send a short form

How should we reach you?

Call